Skip to main content
. 2017 Nov 15;2(11):7959–7975. doi: 10.1021/acsomega.7b00978

Scheme 1. Schematic route postulate the dual drug loading possibilities in PMS nanomaterials that exhibit precise drug releasing behavior in the distinct subcellular regions of cancer environment that improve cancer therapy with synergistic effects.

Scheme 1